Olmesartan Medoxomil
C29H30N6O6
558.59
1H-Imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methyl ethyl)-2-propyl-1-[[2′-(1H-tetrazol-5-yl) [1,1′-biphenyl]-4-yl]methyl]-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester; (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-{[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate [144689-63-4]
1H-Imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methyl ethyl)-2-propyl-1-[[2′-(1H-tetrazol-5-yl) [1,1′-biphenyl]-4-yl]methyl]-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester; (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-{[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate [144689-63-4]
DEFINITION
Olmesartan Medoxomil contains NLT 98.5% and NMT 101.5% of C29H30N6O6, calculated on the anhydrous and solvent-free basis.
USP REFERENCE STANDARDS FOR PURCHASE
USP Olmesartan Medoxomil RSUSP Olmesartan Medoxomil Related Compound A RS